Renewal-NAD+: A Study of Oral NAD+ and Its Multi-omic Impact in a Healthy Cohort

NCT07336836 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Health Adult Subjects
Healthy Participants

Interventions

DIETARY_SUPPLEMENT: LathMized TM NAD+ (LNAD+)
OTHER: Control (placebo)

Sponsor

BioNADrx Holdings, Inc. Bryleos

Collaborators

[object Object]